| Anti-androgenic therapies targeting the luminal androgen receptor of a typical triple-negative breast cancer A Khadela, VP Chavda, S Soni, K Megha, AJ Pandya, L Vora Cancers 15 (1), 233, 2022 | 12 | 2022 |
| Unveiling the antibody–drug conjugates portfolio in battling triple-negative breast cancer: therapeutic trends and future horizon A Khadela, S Soni, AC Shah, AJ Pandya, K Megha, N Kothari, A Cb Medical Oncology 40 (1), 25, 2022 | 9 | 2022 |
| A review on the impact of the SARS-CoV-2 Omicron subvariant on elderly patients with diverse co-morbidities A Khadela, S Soni, K Megha, S Bhagat, VP Chavda Biologics 3 (2), 138-157, 2023 | 4 | 2023 |
| Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects A Khadela, S Soni, K Megha, AC Shah, AJ Pandya, N Kothari, I Shah, ... Medical Oncology 40 (1), 48, 2022 | 4 | 2022 |
| Treatment challenges in developing nations for patients with locally advanced or metastatic head-and-neck cancer A Khadela, S Soni, K Megha Cancer Research, Statistics, and Treatment 6 (1), 139-140, 2023 | 1 | 2023 |
| Exploring the Potential of Antibody-Drug Conjugates in Targeting Non-small Cell Lung Cancer Biomarkers A Khadela, K Megha, VB Shah, S Soni, AC Shah, H Mistry, S Bhatt, ... Clinical Medicine Insights: Oncology 18, 11795549241260534, 2024 | | 2024 |
Dr. Avinash KhadelaL. M. College of Pharmacy, Ahmedabad在 lmcp.ac.in 的电子邮件经过验证
